Clinical implementation of genomic medicine: the importance of global collaboration

Expert Review of Precision Medicine and Drug Development

Volumn 1, Issue 4, 2016, Pages 349-351

  Manolio, Teri A ^a   Ward, Robyn ^b   Ginsburg, Geoffrey S ^c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c DUKE UNIVERSITY   (United States)

Author keywords

Genomic medicine; global collaborations; implementation; medical genomics; personalized medicine; pharmacogenomics

Indexed keywords

EID: 85034707846     PISSN: None     EISSN: 23808993     Source Type: Journal    
DOI: 10.1080/23808993.2016.1192460     Document Type: Editorial

References (26)

1. McCarthy JJ, McLeod HL, Ginsburg GS., Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med. 2013 Jun 12;5(189):189sr4.
2. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013 Apr;15(4):258–267.
3. Human Genomics Strategy Group. Building on our inheritance: genomic technology in healthcare; [cited 2016 Mar 6]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213705/dh_132382.pdf
4. GenomeCanada. 2012 large-scale applied research project competition in genomics and personalized health; [cited 2016 Mar 6]. Available from: http://www.genomecanada.ca/en/programs/large-scale-science/past-competitions/2012-large-scale-applied-research-project-competition
5. Manolio TA, Abramowicz M, Al-Mulla F, et al. Global implementation of genomic medicine: we are not alone. Sci Transl Med. 2015;7:ps13.
6. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet. 2012 Dec 15;380(9859):2055–2058.
7. IeDEA and ART Cohort Collaborations, Avila D, Althoff KN, Mugglin C, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8–e16.
8. National Health and Medical Research Council of Australia. Principles for the translation of ‘omics ’-based tests from discovery to health care; [cited 2016 Mar 6]. Available from: http://consultations.nhmrc.gov.au/files/consultations/drafts/attaevidentialstandardsdocument.pdf
9. Overby CL, Kohane I, Kannry J, et al. Opportunities for genomic clinical decision support interventions. Genet Med. 2013 Oct;15(10):817–823.
10. Ramos EM, Din-Lovinescu C, Berg JS, et al. Characterizing genetic variants for clinical action. Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):93–104.
11. ETRIKS, European Translational Information and Knowledge Management Services. [cited 2016 Mar 6]. Available from: http://www.etriks.org/
12. Committee on a Framework for Development a New Taxonomy of Disease; National National Research Council. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington (DC): National Academies Press; 2011. Available from: www.nap.edu
13. Korf BR, Berry AB, Limson M, et al. Framework for development of physician competencies in genomic medicine: report of the competencies working group of the inter-society coordinating committee for physician education in genomics. Genet Med. 2014 Apr 24;16(11):804–809.
14. Coursera and University of California, San Francisco. Genomic and precision medicine; [cited 2016 Mar 6]. Available from: https://www.coursera.org/course/genomicmedicine
15. Carr DF, Alfirevic A, Pirmohamed M. Pharmacogenomics: current state-of-the-art. Genes (Basel). 2014 May 26;5(2):430–443.
16. Holden AL, Contreras JL, John S, et al. The international serious adverse events consortium. Nat Rev Drug Discov. 2014 Oct 31;13(11):795–796.
17. Pirmohamed M, Burnside G, Eriksson N, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med. 2013 Dec 12;369(24):2294–2303.
18. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011 Mar;89(3):464–467.
19. Landrum MJ, Lee JM, Benson M, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016 Jan 4;44(D1):D862–D868. doi:10.1093/nar/gkv1222.
20. Knoppers BM, Fortier I, Legault D, et al. the public population project in genomics (P3G): a proof of concept? Eur J Hum Genet. 2008 Jun;16(6):664–665.
21. International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, et al. International network of cancer genome projects. Nature. 2010 Apr 15;464(7291):993–998. doi:10.1038/nature08987. Erratum in: Nature. 2010 Jun 17;465(7300):966
22. Global Alliance for Genomics and Health (GA4GH). [cited 2016 Mar 6]. Available from: http://genomicsandhealth.org/
23. Genomics England. The 100,000 genomes project; [cited 2016 Apr 17]. Available from: http://www.genomicsengland.co.uk/the-100000-genomes-project/
24. National Institutes of Health. Precision medicine initiative cohort program; [cited 2016 Apr 17]. Available from: https://www.nih.gov/precision-medicine-initiative-cohort-program
25. Snyder SR, Mitropoulou C, Patrinos GP, et al. Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision-making in the face of complexity. Public Health Genomics. 2014;17(5–6):256–264.
26. National Academy of Medicine. Roundtable on translating genomic-based research for health; [cited 2016 Mar 6]. Available from: http://www.iom.edu/Activities/Research/GenomicBasedResearch.aspx